269 related articles for article (PubMed ID: 1687129)
21. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.
Boner AL; Spezia E; Piovesan P; Chiocca E; Maiocchi G
Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):935-9. PubMed ID: 7908246
[TBL] [Abstract][Full Text] [Related]
22. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
Becker AB; Simons FE
J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732
[TBL] [Abstract][Full Text] [Related]
23. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
Britton MG; Earnshaw JS; Palmer JB
Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
[TBL] [Abstract][Full Text] [Related]
24. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
Lötvall J; Ankerst J
Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
[TBL] [Abstract][Full Text] [Related]
25. Rapid onset of tolerance to beta-agonist bronchodilation.
Haney S; Hancox RJ
Respir Med; 2005 May; 99(5):566-71. PubMed ID: 15823453
[TBL] [Abstract][Full Text] [Related]
26. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomised controlled trial.
Haney S; Hancox RJ
Respir Res; 2005 Sep; 6(1):107. PubMed ID: 16168062
[TBL] [Abstract][Full Text] [Related]
27. Twelve hours' bronchodilating effect of inhaled formoterol in children with asthma: a double-blind cross-over study versus salbutamol.
Graff-Lonnevig V; Browaldh L
Clin Exp Allergy; 1990 Jul; 20(4):429-32. PubMed ID: 1973907
[TBL] [Abstract][Full Text] [Related]
28. Improved lung function and symptom control with formoterol on demand in asthma.
Cheung D; van Klink HC; Aalbers R;
Eur Respir J; 2006 Mar; 27(3):504-10. PubMed ID: 16507849
[TBL] [Abstract][Full Text] [Related]
29. Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial.
Tattersfield AE; Löfdahl CG; Postma DS; Eivindson A; Schreurs AG; Rasidakis A; Ekström T
Lancet; 2001 Jan; 357(9252):257-61. PubMed ID: 11214127
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.
Jenkins C; Kolarikova R; Kuna P; Caillaud D; Sanchis J; Popp W; Pettersson E
Respirology; 2006 May; 11(3):276-86. PubMed ID: 16635085
[TBL] [Abstract][Full Text] [Related]
31. Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study.
Sovijärvi AR; Reinikainen K; Freudenthal Y; Andersson P; Riska H
Respiration; 1992; 59(5):279-82. PubMed ID: 1488561
[TBL] [Abstract][Full Text] [Related]
32. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
[TBL] [Abstract][Full Text] [Related]
33. [Formoterol as inhalation powder in the treatment of patients with reversible obstructive lung diseases. A 3-month placebo-controlled comparison of the effects of formoterol and salbutamol, followed by a 12-month period with formoterol alone].
Steffensen IE; Faurschou P
Ugeskr Laeger; 1996 Dec; 158(49):7092-6. PubMed ID: 8999618
[TBL] [Abstract][Full Text] [Related]
34. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
[TBL] [Abstract][Full Text] [Related]
35. Formoterol, a new long-acting beta 2 agonist, inhaled twice daily, in stable asthmatic subjects.
Midgren B; Melander B; Persson G
Chest; 1992 Apr; 101(4):1019-22. PubMed ID: 1348219
[TBL] [Abstract][Full Text] [Related]
36. Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration.
Löfdahl CG; Svedmyr N
Allergy; 1989 May; 44(4):264-71. PubMed ID: 2544117
[TBL] [Abstract][Full Text] [Related]
37. Inhaled corticosteroid therapy in asthma: a balancing act.
Li JT
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):229-30. PubMed ID: 10094213
[No Abstract] [Full Text] [Related]
38. Long-term efficacy of formoterol compared to salbutamol.
Hekking PR; Maesen F; Greefhorst A; Prins J; Tan Y; Zweers P
Lung; 1990; 168 Suppl():76-82. PubMed ID: 1974686
[TBL] [Abstract][Full Text] [Related]
39. A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma.
Najafizadeh K; Sohrab Pour H; Ghadyanee M; Shiehmorteza M; Jamali M; Majdzadeh S
Emerg Med J; 2007 May; 24(5):317-21. PubMed ID: 17452695
[TBL] [Abstract][Full Text] [Related]
40. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]